Genomma Lab Internacional (GNMLF) Stock Forecast & Price Target

$0.98

0.00 (0.00%)

(As of 07/5/2024 ET)

Stock Analysis Analyst Forecasts Chart Short Interest

Genomma Lab Internacional - Analysts' Recommendations and Stock Price Forecast (2024)

MarketBeat calculates consensus analyst ratings for stocks using the most recent rating from each Wall Street analyst that has rated a stock within the last twelve months. Each analyst's rating is normalized to a standardized rating score of 1 (sell), 2 (hold), 3 (buy) or 4 (strong buy). Analyst consensus ratings scores are calculated using the mean average of the number of normalized sell, hold, buy and strong buy ratings from Wall Street analysts. Each stock's consensus analyst rating is derived from its calculated consensus ratings score (0 to .5 = Strong Sell, .5 to 1 = Sell, 1 to 1.5 = Reduce, 1.5 to 2.5 = Hold, 2.5 to 3.0 = Moderate Buy, 3.0 to 3.5 = Buy, >3.5 = Strong Buy). MarketBeat's consensus price targets are a mean average of the most recent available price targets set by each analyst that has set a price target for the stock in the last twelve months. MarketBeat's consensus ratings and consensus price targets may differ from those calculated by other firms due to differences in methodology and available data.

Consensus Rating

Hold
Based on 1 Analyst Ratings

Consensus Price Target

N/A

Type	Current Forecast 7/6/23 to 7/5/24	1 Month Ago 6/6/23 to 6/5/24	3 Months Ago 4/7/23 to 4/6/24	1 Year Ago 7/6/22 to 7/6/23
Consensus Rating	Hold	Hold	Hold	Hold
Strong Buy	0 Strong Buy rating(s)	0 Strong Buy rating(s)	0 Strong Buy rating(s)	0 Strong Buy rating(s)
Buy	0 Buy rating(s)	0 Buy rating(s)	0 Buy rating(s)	0 Buy rating(s)
Hold	1 Hold rating(s)	1 Hold rating(s)	1 Hold rating(s)	1 Hold rating(s)
Sell	0 Sell rating(s)	0 Sell rating(s)	0 Sell rating(s)	0 Sell rating(s)
Consensus Price Target	N/A	N/A	N/A	N/A
Forecasted Upside	N/A	N/A	N/A	N/A

Get Genomma Lab Internacional Upgrade and Downgrade Alerts

Sign-up to receive the latest news and ratings for GNMLF and its competitors with MarketBeat's FREE daily newsletter.

Ad Crypto Swap Profits

Grab Your Free Bitcoin Today!

And my special guest is willing to give you $10 in Bitcoin (BTC) if you take it seriously. Right now is a very important time to pay attention to what we are doing and what is happening. If you wait... it will be too late. This week we are holding several workshops and if you attend and pay attention my special guest is going to send you $10 in Bitcoin.

>> Register right here

GNMLF Analyst Recommendations By Month

The chart below shows how a company's ratings by analysts have changed over time. Each bar represents the previous year of ratings for that month. Within each bar, the sell ratings are shown in red, the hold ratings are shown in yellow, the buy ratings are shown in green, and the strong buy ratings are shown in dark green.

GNMLF Price Targets by Month

The chart below shows how a company's share price and consensus price target have changed over time. The dark blue line represents the company's actual price. The lighter blue line represents the stock's consensus price target. The even lighter blue range in the background of the two lines represents the low price target and the high price target for each stock.

Genomma Lab Internacional Stock vs. The Competition

Type	Genomma Lab Internacional	Medical Companies	S&P 500
Consensus Rating Score	2.00	2.71	2.50
Consensus Rating	Hold	Moderate Buy	Moderate Buy
Predicted Upside		995.23% Upside	12.26% Upside
News Sentiment Rating	Neutral News	Positive News	Positive News

Recent Analyst Forecasts and Stock Ratings

Rating

Upside/Downside

Action

Time Frame

Start Date

End Date

Show

Export to Excel

Date	Brokerage	Analyst Name	Action	Rating	Price Target	Upside/Downside on Report Date	Details
8/2/2023	Barclays Subscribe to MarketBeat All Access for the recommendation accuracy rating		Downgrade	Overweight ➝ Equal Weight
3/10/2023	UBS Group Subscribe to MarketBeat All Access for the recommendation accuracy rating		Downgrade	Buy ➝ Neutral

Analyst ratings data on MarketBeat is provided by Benzinga and other data providers. This page was last refreshed on Friday at 09:34 PM ET.

GNMLF Forecast - Frequently Asked Questions

Should I buy or sell Genomma Lab Internacional stock right now?: 1 Wall Street equities research analysts have issued "buy," "hold," and "sell" ratings for Genomma Lab Internacional in the last year. There is currently 1 hold rating for the stock. The consensus among Wall Street equities research analysts is that investors should "hold" GNMLF shares. A hold rating indicates that analysts believe investors should maintain any existing positions they have in GNMLF, but not buy additional shares or sell existing shares.
Do Wall Street analysts like Genomma Lab Internacional more than its competitors?: Analysts like Genomma Lab Internacional less than other "medical" companies. The consensus rating for Genomma Lab Internacional is Hold while the average consensus rating for "medical" companies is Moderate Buy. Learn more on how GNMLF compares to other companies.